Phase II Randomised Trial of Cyclophosphamide and Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study evaluates a new treatment combination of ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory multiple myeloma. Participants will either receive ixazomib with cyclophosphamide and dexamethasone or cyclophosphamide and dexamethasone alone.
Epistemonikos ID: f73076e8bee006133418d2f53b375ac286cf166c
First added on: May 12, 2024